CME webinar: 2023 UPMC for Life Medicare Product Training

Jun. 2023Education/Webinars
Please join us for a live, CME-accredited webinar Tuesday, July 11, from 7 a.m. to 8 a.m., that will provide an overview on Medicare.

During this presentation, our expert will discuss:
  • The difference between Medicare Fee for Service and Medicare Advantage, why Medicare Advantage exists, and where it’s going in the future.
  • The importance of value-based care.
  • UPMC Health Plan’s Medicare Advantage Plan, UPMC for Life.
  • Care managers and what they do, optimizing information flow.
  • Health outcomes, accountability for costs, and why this is a better patient experience.

Presenter:
  • Barbara Kevish MD, AVP, Medicare Medical Services, UPMC Health Plan

Register now. This webinar will be recorded.

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.

Recent Announcements

Important announcement – Telehealth submissions

As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.
Sep. 2025Important Notices

October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update

Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.
Sep. 2025Pharmacy Updates

Biosimilar Medication Formulary Updates

Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab products
Sep. 2025Pharmacy Updates